Showing results (61-70 of 5,189) with videos related to

Sort By:
Pageof 519
Investigative Radiology|August 1, 1990
Gd-DOTA. Pharmacokinetics and tolerability after intravenous injection into healthy volunteersM M Le Mignon, C Chambon, S Warrington, et al.
Clinical Pharmacology and Therapeutics|February 1, 1983
Effects of intravenous epoprostenol on platelets and the cardiovascular system are not potentiated by dipyridamoleH Pickles, A Fish, S Hassan, et al.
Ecological Applications : a Publication of the Ecological Society of America|February 8, 2013
Estimating landscape carrying capacity through maximum clique analysisTherese M Donovan, Gregory S Warrington, W Scott Schwenk, et al.
British Journal of Clinical Pharmacology|September 1, 1982
The cardiovascular and platelet effects of epoprostenol (prostacyclin, PGI2) are unaffected by beta-adrenoceptor blockade in manS Hassan, H Pickles, A Fish, et al.
The Journal of Pharmacy and Pharmacology|July 3, 2004
Phenacetin and chlorzoxazone biotransformation in aging male Fischer 344 ratsJill S Warrington, Michael H Court, David J Greenblatt, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|May 23, 2002
In vitro biotransformation of sildenafil (Viagra) in the male rat: the role of CYP2C11Jill S Warrington, Lisa L Von Moltke, Richard I Shader, et al.
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|May 9, 2000
A five way crossover human volunteer study to compare the pharmacokinetics of paracetamol following oral administration of two commercially available paracetamol tablets and three development tablets containing paracetamol in combination with sodium bicarbonate or calcium carbonateT Grattan, R Hickman, A Darby-Dowman, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|March 22, 2000
In vitro biotransformation of sildenafil (Viagra): identification of human cytochromes and potential drug interactionsJ S Warrington, R I Shader, L L von Moltke, et al.
Dermatologic Therapy|August 16, 2003
Diagnosis and management of the erythropoietic porphyriasGillian M Murphy
Pageof 519